2003
DOI: 10.1128/jcm.41.7.3028-3034.2003
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Enteroviruses by Using Monoclonal Antibodies against a Putative Common Epitope

Abstract: A common epitope region of enteroviruses was identified by sequence-independent single-primer amplification (SISPA), followed by immunoscreening of 11 cDNA libraries from two Korean enterovirus isolates (echoviruses 7 and 30) and a coxsackievirus B3 (ATCC-VR 30). The putative common epitope region was localized in the N terminus of VP1 when the displayed recombinant proteins from the phages were chased by the convalescent-phase sera. The genomic region encoding the common epitope region was amplified and then … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 36 publications
(40 reference statements)
0
10
0
Order By: Relevance
“…EV capsid protein VP1 is one of four structural proteins of EV, and its antigenic homology among many different EV serotypes has been well documented (2,7,(16)(17)(18). The N termini of most EV VP1 proteins contain highly conserved immunogenic regions that are recognized by sera from most EV-infected patients (2).…”
Section: Human Enteroviruses (Evs) Are Classified Into Four Speciesmentioning
confidence: 99%
See 1 more Smart Citation
“…EV capsid protein VP1 is one of four structural proteins of EV, and its antigenic homology among many different EV serotypes has been well documented (2,7,(16)(17)(18). The N termini of most EV VP1 proteins contain highly conserved immunogenic regions that are recognized by sera from most EV-infected patients (2).…”
Section: Human Enteroviruses (Evs) Are Classified Into Four Speciesmentioning
confidence: 99%
“…However, the two commercially available pan-EV MAbs used in the staining assay either fail to react with multiple EV serotypes (9, 19) or cross-react with other non-EVs (8, 22). The lack of availability of highly reactive and specific pan-EV MAbs for diagnosis of EV infection could be due to the difficulties in developing specific MAbs against the extensive antigenic diversity among EVs.EV capsid protein VP1 is one of four structural proteins of EV, and its antigenic homology among many different EV serotypes has been well documented (2,7,(16)(17)(18). The N termini of most EV VP1 proteins contain highly conserved immunogenic regions that are recognized by sera from most EV-infected patients (2).…”
mentioning
confidence: 99%
“…Also, sequence-independent amplification of DNA has been used for the molecular cloning of specific microdissected DNA chromosomal regions [13]. Finally, a common epitope region of enteroviruses has been identified by SISPA followed by immunoscreening [33].…”
Section: Other Adaptationsmentioning
confidence: 99%
“…3B) (9,17,18,23,25). In addition, many amino acid differences were observed between strains 2002-240-SF and Del Carmen in the VP1 region, of which the N and C termini were, respectively, common epitopes of enteroviruses (27,29).…”
Section: Vol 17 2010 Seroprevalence Of E13 Between 2000 and 2003 765mentioning
confidence: 99%
“…When the amino acid sequences of strains 2002-240-SF and Del Carmen were compared, differences of 1, 7, 6, and 25 amino acids were observed in the VP4, VP2, VP3, and VP1 regions, respectively. Although the neutralization antigenic sites (N-Ags) and the crystal structure of E13 have not been determined, the N-Ags of other enteroviruses have been reported and some of them are in the same position (4,17,18,25,27,29). Therefore, the amino acid sequence differences between strains 2002-240-SF and Del Carmen were compared with the N-Ags of other enteroviruses on the three-dimen- , respectively, are projected onto the E11 structure (Protein Data Bank number 1h8t; original source of structural data, reference 30; used with permission).…”
Section: Vol 17 2010 Seroprevalence Of E13 Between 2000 and 2003 765mentioning
confidence: 99%